Cozad Asset Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
VCM
VPM
Cozad Asset Management's EW Position: Q1 2026 in Review
Cozad Asset Management sold out of Edwards Lifesciences (EW) in Q1 2026, closing a stake of 2,448 shares — an estimated $209K sold.
Cozad Asset Management first reported a position in EW in Q3 2019 and held it in 18 quarters. The position peaked at $3.13M in Q4 2020. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.
- Cozad Asset Management reported no remaining Edwards Lifesciences position as of Q1 2026 after selling out during the quarter.
- Cozad Asset Management sold 2,448 Edwards Lifesciences shares in Q1 2026, an estimated $209K.
- Cozad Asset Management first reported a position in Edwards Lifesciences in Q3 2019 and held it in 18 quarters.
- Cozad Asset Management's Edwards Lifesciences position peaked at $3.13M in Q4 2020.
- 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.
Based on Cozad Asset Management's 13F filing for Q1 2026, filed 28 May 2026.